Third Wave Technologies RSS Feed | Nachrichten | finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-deSmartHouse Media GmbHhttp://finanzen.net/images/finanzen_net.gifFinanzen.nethttp://www.finanzen.netThird Wave to Present at 33rd Annual Deutsche Bank Health Care Conferencehttp://www.finanzen.net/nachricht/Third_Wave_to_Present_at_33rd_Annual_Deutsche_Bank_Health_Care_Conference_717864Third Wave Technologies Inc. (NASDAQ:TWTI) today announced that it will present at the 33rd Annual Deutsche Bank Health Care Conference, which is being held May 5-7, 2008, at the InterContinental Hotel in Boston. Maneesh K. Arora, ...http://www.finanzen.net/nachricht/Third_Wave_to_Present_at_33rd_Annual_Deutsche_Bank_Health_Care_Conference_717864Third Wave Reports First-Quarter Financial Resultshttp://www.finanzen.net/nachricht/Third_Wave_Reports_First_Quarter_Financial_Results_717525Third Wave Technologies Inc. (NASDAQ: TWTI) today announced its financial results for the quarter ended March 31, 2008. Third Wave reported clinical molecular diagnostic revenue of $7.4 million for the first quarter of 2008, ...http://www.finanzen.net/nachricht/Third_Wave_Reports_First_Quarter_Financial_Results_717525Third Wave Completes FDA Submissions for Its Two HPV Productshttp://www.finanzen.net/nachricht/Third_Wave_Completes_FDA_Submissions_for_Its_Two_HPV_Products_714877Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that the company has submitted the pre-market approval (PMA) applications for its two human papillomavirus, or HPV, testing products to the U.S. Food and Drug Administration. ...http://www.finanzen.net/nachricht/Third_Wave_Completes_FDA_Submissions_for_Its_Two_HPV_Products_714877Third Wave to Host First-Quarter 2008 Conference Callhttp://www.finanzen.net/nachricht/Third_Wave_to_Host_First_Quarter_2008_Conference_Call_712162Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that the company will host a conference call and question-and-answer session on May 1, 2008, at 10 a.m. ET, to discuss the company's first-quarter 2008 financial results. ...http://www.finanzen.net/nachricht/Third_Wave_to_Host_First_Quarter_2008_Conference_Call_712162Third Wave to Present at Leerink Swann Molecular Diagnostics Roundtable Conferencehttp://www.finanzen.net/nachricht/Third_Wave_to_Present_at_Leerink_Swann_Molecular_Diagnostics_Roundtable_Conference_700526Third Wave Technologies Inc. (NASDAQ:TWTI) today announced that it will present at the Leerink Swann Molecular Diagnostics Roundtable Conference, which is being held April 3, 2008, at the Sofitel New York. Kevin T. Conroy, Third Wave's ...http://www.finanzen.net/nachricht/Third_Wave_to_Present_at_Leerink_Swann_Molecular_Diagnostics_Roundtable_Conference_700526Third Wave, DCL Medical Laboratories Form Strategic Partnershiphttp://www.finanzen.net/nachricht/Third_Wave_DCL_Medical_Laboratories_Form_Strategic_Partnership_696189Third Wave Technologies Inc. (NASDAQ: TWTI), a leader in molecular diagnostics, and DCL Medical Laboratories LLC, Indianapolis, a full-service reference laboratory focused on women’s health, today announced the formation of a strategic ...http://www.finanzen.net/nachricht/Third_Wave_DCL_Medical_Laboratories_Form_Strategic_Partnership_696189Third Wave's InPlex(TM) CF Molecular Test Receives FDA Clearancehttp://www.finanzen.net/nachricht/Third_Wave_s_InPlex_TM_CF_Molecular_Test_Receives_FDA_Clearance_693454Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that the company has received clearance from the U.S. Food and Drug Administration of its InPlex™ CF Molecular Test. The test simultaneously detects and identifies cystic ...http://www.finanzen.net/nachricht/Third_Wave_s_InPlex_TM_CF_Molecular_Test_Receives_FDA_Clearance_693454Third Wave's HPV Clinical Trial Achieves Primary Clinical Endpointshttp://www.finanzen.net/nachricht/Third_Wave_s_HPV_Clinical_Trial_Achieves_Primary_Clinical_Endpoints_691272Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that the company achieved all primary clinical endpoints in the clinical trial for its human papillomavirus (HPV) tests. The company expects to submit the trial results to ...http://www.finanzen.net/nachricht/Third_Wave_s_HPV_Clinical_Trial_Achieves_Primary_Clinical_Endpoints_691272Third Wave Reports Strong Full-Year 2007 Results, Continued Clinical Revenue Growthhttp://www.finanzen.net/nachricht/Third_Wave_Reports_Strong_Full_Year_2007_Results_Continued_Clinical_Revenue_Growth_682584Third Wave Technologies Inc. (NASDAQ: TWTI) today announced its financial results for the year ended Dec. 31, 2007. Third Wave reported clinical molecular diagnostic revenue of $26.3 million for the year ended Dec. 31, 2007, ...http://www.finanzen.net/nachricht/Third_Wave_Reports_Strong_Full_Year_2007_Results_Continued_Clinical_Revenue_Growth_682584Third Wave Announces Filing of Shelf Registration Statementhttp://www.finanzen.net/nachricht/Third_Wave_Announces_Filing_of_Shelf_Registration_Statement_675378Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that it has filed a universal shelf registration statement with the U.S. Securities and Exchange Commission (SEC). The company has no specific plans to offer the securities ...http://www.finanzen.net/nachricht/Third_Wave_Announces_Filing_of_Shelf_Registration_Statement_675378